|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 对比增强超声肝纤维化分期与METAVIR评分的多中心前瞻性研究显示文摘对99例活检诊断肝纤维化病人的对比增强超声评估肝纤维化程度进行了前瞻性评价。根据每条静脉内微泡到达时间的不同,计算门静脉与肝静脉间的微泡通过时间。对比增强超声检查后6个月内每例病人均接受了肝活检。组织学纤维化分为2级:①没有或中度纤维化(METAVIR分期的F0、F1与F2)或②重度纤维化(F3与F4)。 | F.Staub C.Tournoux-Facon J.Roumy C.Chaigneau M.Morichaut Beauchant P.Levillain 唐光健 | 2009 | 国际医学放射学杂志2009，32，5： | 9 |
| 2 | Management of digestive bleeding related to portal hypertension in cirrhotic patients:A French multicenter cross-sectional practice survey显示文摘AIM: To investigate the conformity of management practices of gastrointestinal hemorrhage in cirrhotic patients with relevant guidelines. METHODS: A questionnaire on the management of digestive bleeding was completed for all consecutive cirrhotic patients admitted to 31 French hospitals. RESULTS: One hundred and twenty-six bleeding events were recorded. It was the first bleeding episode in 79 patients (63%), of whom 40 (51%) had a prior diagnosis of cirrhosis and 25 (32%) had previously undergone an endoscopy. The bleeding episode was a recurrence in 46 patients (37%). The median time between onset and admission was 4 h, but exceeded 12 h in 42% of cases. There was an agreement between centers forearly vasoactive drug administration (87% of cases), association with ligation (42%) more often than sclerosis (21%) at initial endoscopy, and antibiotic prophylaxis (64%). By contrast, prescription of beta-blockade alone or in combination (0 to 100%, P = 0.003) for secondary prophylaxis and lactulose (26% to 86%, P = 0.04), differed among centers. CONCLUSION: In French hospitals, management of bleeding related to portal hypertension in cirrhotic patients is generally in keeping with the consensus. Broad variability still remains concerning beta-blockade use for secondary prophylaxis. Screening for esophageal varices, the use of antibiotic prophylaxis and patients information need to be improved. | Pierre Ingrand Jérme Gournay Pierre Bernard Frédéric Oberti Brigitte Bernard-Chabert Arnault Pauwels Philippe Renard Eric Bartoli Jean-Franois Cadranel Jean-Claude Barbare Isabelle Ingrand Michel Beauchant | 2006 | World Journal of Gastroenterology2006，12，48： | 4 |
| 3 | Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial显示文摘 | M. Beauchant P. Ingrand J. Favriel J. Dupuychaffray P. Capony H. Moindrot M. Barthet J. Escourrou C. Plane T. Barrioz L. Lacoste I. Ingrand | 2008 | Endoscopy2008，，08： | 1 |
| 4 | Syndrome de Rapunzel associé à une intussusception du grêle, une dilatation des voies biliaires et une pancréatite显示文摘 | Bruno Godart Marc Wangermez Carole Doucet Jean-Pierre Faure Michel Beauchant | 2006 | Gastroenterologie Clinique et Biologique2006，，11： | 1 |
| 5 | Prevention of Biliary Stent Occlusion by Ursodeoxycholic Acid plus Norfloxacin显示文摘 | V. de Lédinghen B. Person J.L. Legoux A. Le Sidaner B. Desaint M. Greff C. Moesch G. Grollier P. Ingrand D. Sautereau M. Beauchant | 2000 | Digestive Diseases and Sciences2000，，1： | 1 |
| 6 | Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography:a randomized,double-blind,placebo-controlled multicenter trial显示文摘 | Beauchant M Ingrand P Favriel JM | | 0，，8： | 1 |
| 7 | Determimants ofparticipation in colonscopic screening by siblings of colorectal cancerpatients in France 显示文摘 | Taouqi M Ingrand I Beauchant M | 2010 | BMC Cancer2010，10，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员